Long‐Term Follow‐Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis-Reference-Cited by-同舟云学术

Long‐Term Follow‐Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis

Published:2020-12-31 Issue:6 Volume:131 Page:
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Evers Georg¹^ORCID,Schliemann Christoph¹,Beule Achim²,Schmidt Lars‐Henning¹,Schulze Arik B.¹,Kessler Christina³,Hoffmann Thomas K.⁴,Wiewrodt Rainer¹,Groll Andreas H.⁵,Bleckmann Annalen¹,Rudack Claudia²,Berdel Wolfgang E.¹,Mohr Michael¹

Affiliation:

1. Department of Medicine A, Hematology, Oncology and Pneumology University Hospital Muenster Muenster Germany

2. Department of Otolaryngology/Head and Neck Cancer University Hospital Muenster Muenster Germany

3. Department of Pediatrics University Hospital Muenster Muenster Germany

4. Department of Otolaryngology/Head and Neck Cancer University Hospital Ulm Ulm Germany

5. Department of Pediatric Hematology/Oncology University Hospital Muenster Muenster Germany

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lary.29351

Reference20 articles.

1. Recurrent Respiratory Papillomatosis with Lung Involvement

2. A prospective study of the incidence of juvenile‐onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program;Novakovic D;J Infect Dis,2018

3. Update on Recurrent Respiratory Papillomatosis

4. American Society of Pediatric Otolaryngology Members' Experience With Recurrent Respiratory Papillomatosis and the Use of Adjuvant Therapy

5. Use of Adjuvant Intralesional Bevacizumab for Aggressive Respiratory Papillomatosis in Children

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis;The Laryngoscope;2024-08-03

2. VEGF as a Key Actor in Recurrent Respiratory Papillomatosis: A Narrative Review;Current Issues in Molecular Biology;2024-07-01

3. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience;The Laryngoscope;2024-03-25

4. Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement;The Laryngoscope;2023-07-20

5. Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis;Annals of Otology, Rhinology & Laryngology;2023-07-12